We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B Turnover 4.85%
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+647.83%
AUM
$43.9B
AUM Growth
+$2.15B
Cap. Flow
+$941M
Cap. Flow %
2.15%
Top 10 Hldgs %
38.78%
Holding
1,752
New
25
Increased
441
Reduced
297
Closed
24
Avg Time Held
5.6 years
Top 10 Avg Time Held
4.6 years
Top 20 Avg Time Held
3.4 years

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$166M
2
MU icon
Micron Technology
MU
+$148M
3
FERG icon
Ferguson
FERG
+$131M
4
AMD icon
Advanced Micro Devices
AMD
+$107M
5
GEV icon
GE Vernova
GEV
+$94.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$262M
2
TMUS icon
T-Mobile US
TMUS
+$167M
3
VZ icon
Verizon
VZ
+$114M
4
NFLX icon
Netflix
NFLX
+$84.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$74.2M

Sector Composition

Rank Sector Weight
1 Technology 34.5%
2 Healthcare 13.82%
3 Communication Services 13.35%
4 Financials 13.33%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CURB icon
1501
Curbline Properties
CURB
$3.05B
$70K ﹤0.01%
3,000
– –
2024 Q4
4 quarters
ACLX icon
1502
DELISTED
Arcellx
ACLX
$69K ﹤0.01%
1,056
– –
2024 Q1
7 quarters
CC icon
1503
Chemours
CC
$1.92B
$69K ﹤0.01%
5,812
– –
2023 Q3
9 quarters
EPAC icon
1504
Enerpac Tool Group
EPAC
$1.8B
$69K ﹤0.01%
1,804
– –
2022 Q2
14 quarters
HRMY icon
1505
Harmony Biosciences
HRMY
$2.21B
$69K ﹤0.01%
1,844
– –
2022 Q2
14 quarters
HUN icon
1506
Huntsman Corp
HUN
$1.5B
$69K ﹤0.01%
6,899
– –
2023 Q3
9 quarters
SMR icon
1507
NuScale Power
SMR
$2.39B
$69K ﹤0.01%
4,871
+1,690
+53% +$48.3K
2024 Q4
4 quarters
WLDN icon
1508
Willdan Group
WLDN
$1.1B
$69K ﹤0.01%
667
– –
2025 Q3
1 quarter
FCPT icon
1509
Four Corners Property Trust
FCPT
$2.41B
$68K ﹤0.01%
2,959
– –
2022 Q2
14 quarters
HOG icon
1510
Harley-Davidson
HOG
$2.78B
$68K ﹤0.01%
3,334
– –
2023 Q3
9 quarters
RARE icon
1511
Ultragenyx Pharmaceutical
RARE
$1.43B
$68K ﹤0.01%
2,941
– –
2023 Q3
9 quarters
SRPT icon
1512
Sarepta Therapeutics
SRPT
$1.81B
$68K ﹤0.01%
3,152
– –
2023 Q3
9 quarters
TRIP icon
1513
TripAdvisor
TRIP
$1.09B
$68K ﹤0.01%
4,680
– –
2024 Q1
7 quarters
WD icon
1514
Walker & Dunlop
WD
$1.12B
$68K ﹤0.01%
1,136
– –
2022 Q2
14 quarters
ZD icon
1515
Ziff Davis
ZD
$1.96B
$68K ﹤0.01%
1,948
– –
2023 Q3
9 quarters
ADUS icon
1516
Addus HomeCare
ADUS
$2.17B
$67K ﹤0.01%
628
– –
2022 Q2
14 quarters
AGM icon
1517
Federal Agricultural Mortgage
AGM
$2.21B
$67K ﹤0.01%
382
– –
2025 Q1
3 quarters
BLBD icon
1518
Blue Bird Corp
BLBD
$1.95B
$67K ﹤0.01%
1,420
– –
2024 Q2
6 quarters
CHCO icon
1519
City Holding Co
CHCO
$1.99B
$67K ﹤0.01%
566
– –
2022 Q2
14 quarters
CRVL icon
1520
CorVel
CRVL
$4.03B
$67K ﹤0.01%
987
– –
2019 Q2
26 quarters
EVTC icon
1521
Evertec
EVTC
$1.86B
$67K ﹤0.01%
2,300
– –
2022 Q2
14 quarters
QDEL icon
1522
QuidelOrtho
QDEL
$885M
$67K ﹤0.01%
2,349
– –
2023 Q3
9 quarters
TDOC icon
1523
Teladoc Health
TDOC
$1.03B
$67K ﹤0.01%
9,632
+4,516
+88% +$35.4K
2023 Q3
9 quarters
TWST icon
1524
Twist Bioscience
TWST
$8.8B
$67K ﹤0.01%
2,121
– –
2023 Q3
9 quarters
CDNA icon
1525
CareDx
CDNA
$3.31B
$66K ﹤0.01%
3,526
– –
2024 Q3
5 quarters

Similar funds

KBC Group's Q4 2025 Portfolio in Review

As of Q4 2025, KBC Group held 1,752 positions worth $43.9B, up 5.2% from $41.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 2.8%. KBC Group opened 25 new positions and exited 24, leaving the 1,752-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.

  • KBC Group's largest Q4 2025 buy was Qnity Electronics Inc: 149,289 shares worth $12.2M.
  • KBC Group added most to Abbott in Q4 2025, an estimated $166M increase.
  • KBC Group's biggest Q4 2025 reduction was T-Mobile US, cutting an estimated $167M.
  • KBC Group fully exited AbbVie in Q4 2025, selling an estimated $262M.
  • KBC Group's ten largest holdings make up 39% of its $43.9B portfolio in Q4 2025.
  • KBC Group opened 25 new positions and closed 24 in Q4 2025.
  • KBC Group's portfolio value rose 5.2% quarter-over-quarter to $43.9B.

Based on KBC Group's 13F filing for Q4 2025, filed 26 Jan 2026.